| For: | Xu Y, Wang XS, Zhou XL, Lu WM, Tang XK, Jin Y, Ye JS. Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies. World J Gastroenterol 2024; 30(32): 3766-3782 [PMID: 39221071 DOI: 10.3748/wjg.v30.i32.3766] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i32/3766.htm |
| Number | Citing Articles |
| 1 |
Xuan Pan, Tianyun Gao, Bin Wang. Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells. Cell & Bioscience 2025; doi: 10.1186/s13578-025-01520-9
|
| 2 |
Yanqiu Li, Bingbing Zhu, Ke Shi, Yu Lu, Xuanwei Zeng, Yongqi Li, Qun Zhang, Ying Feng, Xianbo Wang. Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1515400
|
| 3 |
Tingyu Yang, Xinqi Xu, Jiapan An, Bin Li, Zhimin Dou. Mesenchymal stem cells in sepsis-induced organ dysfunction: mechanisms and therapeutic potential. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04752-1
|
| 4 |
Wahyu Widowati, Adilah Hafizha Nur Sabrina, Annisa Firdaus Sutendi, Fadhilah Haifa Zahiroh, Aris Muhamad Nurjamil, Teresa Liliana Wargasetia, Ita Margaretha Nainggolan, Rizal Azis, Elham Rismani, Massoud Vosough, Poorani Gurumallesh Prabu. Immune System and Hepatic Stellate Cells’ Crosstalk in Liver Fibrosis: Pathways and Therapeutic Potential. Journal of Immunology Research 2026; 2026(1) doi: 10.1155/jimr/2656395
|
